查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951949

生物技術原料市場分析及預測（至2035年）：依類型、產品類型、服務、技術、成分、應用、形式、製程及最終用戶分類

Biotech Ingredients Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Form, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 336 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

生技原料市場預計將從2024年的29億美元成長到2034年的73億美元，複合年成長率約為8.1%。生物技術原料市場涵蓋製藥、化妝品和食品產業所使用生物基物質的生產和應用。這些原料生物來源，為產品配方提供永續的創新解決方案。生物技術的進步、消費者對天然產品日益成長的需求以及對環保實踐的監管支持是推動市場成長和多元化發展的促進因素，這些因素正在促進生物技術原料市場在各種應用領域的發展。

生物技術原料市場預計將迎來顯著成長，這主要得益於生物技術的進步和對永續解決方案日益成長的需求。製藥領域正成為成長最快的細分市場，這主要受創新藥物配方和個人化醫療需求的推動。在該領域，酶因其在藥物合成和生物催化方面的應用而備受關注。化妝品和個人護理行業也緊隨其後，胜肽和蛋白質等活性成分能夠提升產品功效和消費者吸引力。機能性食品原料市場也在蓬勃發展，這主要得益於人們健康意識的提高和對強化食品的需求。益生菌和益生元因其對促進腸道健康和整體健康的關鍵作用而脫穎而出。生物技術衍生的香精香料作為合成化合物的天然永續替代品，也越來越受到重視。持續的研發投入和策略合作推動了市場成長，這些投入和合作正在推動創新並加速產品開發。

市場區隔
類型 胺基酸、酵素、維生素、有機酸、抗生素、荷爾蒙、生物聚合物
產品 重組蛋白、單株抗體、疫苗、細胞培養基、生物製藥、診斷劑
服務 契約製造、客製化合成、製程開發、分析服務、諮詢和法規支持
科技 發酵、生物催化、細胞培養、基因工程、合成生物學、代謝工程
成分 原料、中間體、活性成分、添加劑
目的 製藥、食品飲料、農業、化妝品、飼料、生質燃料
形式 液體、粉末、顆粒、丸劑
過程 上游工程、下游製程、配方、純化
最終用戶 製藥公司、生技公司、研究機構、受託研究機構

生技原料市場呈現動態的市場格局，創新和策略聯盟對市場佔有率有顯著影響。新產品的推出和對成本效益的追求導致了日益激烈的定價競爭。近期產品推出豐富了產品線，提升了生物技術原料在各個細分市場的吸引力。各公司正利用技術進步來最佳化生產流程、維持競爭優勢並確保永續成長。競爭基準分析顯示，該市場競爭異常激烈，主要企業透過研發爭奪主導。在安全和品質標準嚴格的地區，法規的影響尤其顯著。這些法規塑造了市場動態，並迫使企業遵守嚴格的合規措施。在對永續和生物基解決方案日益成長的需求驅動下，該市場展現出強勁的成長潛力。隨著創新不斷加速，在生物技術進步和消費者對環保產品偏好的推動下，生物技術原料市場可望迎來變革性成長。

主要趨勢和促進因素：

受消費者對永續和天然來源產品需求不斷成長的推動，生技原料市場正經歷顯著成長。一個關鍵趨勢是轉向生物基原料，這主要源自於消費者對環保產品的偏好。生物技術的進步進一步推動了這一趨勢，使得高品質、永續原料的生產成為可能。另一個重要趨勢是個人化營養的興起，這推動了對根據個人健康需求量身定做的生物技術原料的需求。此外，製藥業在藥物製劑中對生技原料的日益依賴也是一個關鍵促進因素。市場也看到研發投入不斷增加，致力於開發具有增強功能的新型原料。新興市場對生技原料的需求正在快速成長，這帶來了巨大的機會。專注於創新和永續性的公司將佔據有利地位，從而獲得市場佔有率。此外，策略夥伴關係和合作對於利用專業知識和擴展產品系列至關重要，這將有助於企業在這個充滿活力的市場中獲得競爭優勢。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 胺基酸
    • 酵素
    • 維他命
    • 有機酸
    • 抗生素
    • 荷爾蒙
    • 生物聚合物
  • 市場規模及預測：依產品分類
    • 重組蛋白
    • 單株抗體
    • 疫苗
    • 細胞培養基
    • 生物製藥
    • 診斷劑
  • 市場規模及預測：依服務分類
    • 契約製造
    • 客製合成
    • 製程開發
    • 分析服務
    • 諮詢
    • 監管支持
  • 市場規模及預測：依技術分類
    • 發酵
    • 生物催化劑
    • 細胞培養
    • 基因工程
    • 合成生物學
    • 代謝工程
  • 市場規模及預測：依組件分類
    • 原料
    • 中級
    • 活性成分
    • 添加劑
  • 市場規模及預測：依應用領域分類
    • 製藥
    • 飲食
    • 農業
    • 化妝品
    • 動物飼料
    • 生質燃料
  • 市場規模及預測：依類型
    • 液體
    • 粉末
    • 顆粒
    • 顆粒
  • 市場規模及預測：依製程分類
    • 上游工程
    • 下游工藝
    • 配方
    • 純化
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 生技公司
    • 研究所
    • 合約研究機構

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Lonza Group
  • Catalent
  • Evonik Industries
  • Fujifilm Diosynth Biotechnologies
  • Corbion
  • Wacker Chemie
  • Croda International
  • Novozymes
  • Merck KGa A
  • Bio Vectra
  • Cambrex Corporation
  • Ajinomoto Bio Pharma Services
  • Sartorius
  • Genomatica
  • Almac Group
  • Boehringer Ingelheim Bio Xcellence
  • Ginkgo Bioworks
  • Biocon
  • Rentschler Biopharma
  • AGC Biologics

第9章：關於我們

簡介目錄
Product Code: GIS32197

Biotech Ingredients Market is anticipated to expand from $2.9 billion in 2024 to $7.3 billion by 2034, growing at a CAGR of approximately 8.1%. The Biotech Ingredients Market encompasses the production and utilization of bio-based substances used in pharmaceuticals, cosmetics, and food industries. These ingredients, derived from living organisms, offer sustainable and innovative solutions for product formulation. The market is driven by advances in biotechnology, increasing consumer demand for natural products, and regulatory support for eco-friendly practices, fostering growth and diversification across applications.

The Biotech Ingredients Market is poised for significant growth, driven by advancements in biotechnology and increasing demand for sustainable solutions. The pharmaceutical segment emerges as the top-performing sub-segment, propelled by the need for innovative drug formulations and personalized medicine. Enzymes, within this segment, are gaining prominence due to their application in drug synthesis and biocatalysis. The cosmetics and personal care sub-segment follows closely, with active ingredients like peptides and proteins enhancing product efficacy and consumer appeal. Functional food ingredients are also witnessing an upward trajectory, fueled by the rising health consciousness and demand for fortified foods. Probiotics and prebiotics stand out as key contributors, promoting gut health and overall well-being. Biotech flavors and fragrances are gaining traction, offering natural and sustainable alternatives to synthetic compounds. The market's growth is underpinned by continuous R&D investments and strategic collaborations, fostering innovation and expediting product development.

Market Segmentation
TypeAmino Acids, Enzymes, Vitamins, Organic Acids, Antibiotics, Hormones, Biopolymers
ProductRecombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Culture Media, Biopharmaceuticals, Diagnostic Reagents
ServicesContract Manufacturing, Custom Synthesis, Process Development, Analytical Services, Consultancy, Regulatory Support
TechnologyFermentation, Biocatalysis, Cell Culture, Genetic Engineering, Synthetic Biology, Metabolic Engineering
ComponentRaw Materials, Intermediates, Active Ingredients, Excipients
ApplicationPharmaceutical, Food and Beverage, Agriculture, Cosmetics, Animal Feed, Biofuels
FormLiquid, Powder, Granule, Pellet
ProcessUpstream Processing, Downstream Processing, Formulation, Purification
End UserPharmaceutical Companies, Biotechnology Firms, Research Institutes, Contract Research Organizations

The Biotech Ingredients Market is characterized by a dynamic landscape where market share is primarily influenced by innovation and strategic alliances. Pricing strategies are increasingly competitive, driven by the introduction of novel products and the pursuit of cost efficiency. Recent product launches have diversified offerings, enhancing the appeal of biotech ingredients across various sectors. Companies are leveraging technological advancements to optimize production processes, thereby maintaining a competitive edge and ensuring sustainable growth. Competition benchmarking reveals a market marked by intense rivalry, with key players vying for leadership through research and development. Regulatory influences are significant, particularly in regions with stringent safety and quality standards. These regulations shape market dynamics, compelling companies to adhere to rigorous compliance measures. The market exhibits robust growth potential, fueled by increasing demand for sustainable and bio-based solutions. As innovation continues to accelerate, the biotech ingredients market is poised for transformative growth, driven by advancements in biotechnology and consumer preference for eco-friendly products.

Geographical Overview:

The biotech ingredients market is experiencing notable growth across various regions, each presenting unique opportunities. North America leads, driven by advanced biotech research and a robust pharmaceutical industry. The region's focus on innovation and sustainable practices further propels market growth. Europe follows, with strong regulatory frameworks and investments in biotechnology fostering a conducive environment for market expansion. Asia Pacific is emerging as a significant growth pocket, fueled by increasing investments in biotech research and development. Countries like China and India are at the forefront, leveraging their vast resources and skilled workforce. Latin America and the Middle East & Africa are also gaining traction, with rising awareness and adoption of biotech solutions. Brazil and South Africa are key players, recognizing the potential of biotech ingredients in enhancing various industries. These regions offer lucrative opportunities for stakeholders aiming to capitalize on the burgeoning demand for sustainable and innovative biotech solutions.

Global tariffs and geopolitical risks are significantly influencing the Biotech Ingredients Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are diversifying their supply chains to mitigate tariff impacts, investing in local biotech innovation. China, facing trade tensions, is accelerating the development of its domestic biotech capabilities, while Taiwan's strategic position in the semiconductor industry also affects its biotech sector. The global market for biotech ingredients is robust, driven by demand for innovative pharmaceuticals and sustainable solutions. By 2035, the market is poised for substantial growth, contingent on geopolitical stability and supply chain resilience. Middle East conflicts add complexity, potentially disrupting global supply chains and affecting energy prices, which in turn could influence production costs and timelines in the biotech sector.

Key Trends and Drivers:

The biotech ingredients market is experiencing notable growth, driven by the increasing demand for sustainable and natural products. Key trends include the shift towards bio-based ingredients, fueled by consumer preference for environmentally friendly products. This trend is further supported by advancements in biotechnology, enabling the production of high-quality, sustainable ingredients. Another significant trend is the rise in personalized nutrition, which is driving the demand for customized biotech ingredients tailored to individual health needs. Additionally, the pharmaceutical industry's growing reliance on biotech ingredients for drug formulation is a crucial driver. The market is also witnessing increased investment in research and development to create novel ingredients with enhanced functionalities. Opportunities are abundant in emerging markets, where the demand for biotech ingredients is expanding rapidly. Companies focusing on innovation and sustainability are well-positioned to capture market share. Furthermore, strategic partnerships and collaborations are becoming essential to leverage expertise and expand product portfolios, ensuring competitive advantage in this dynamic market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Form
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by End User

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Amino Acids
    • 4.1.2 Enzymes
    • 4.1.3 Vitamins
    • 4.1.4 Organic Acids
    • 4.1.5 Antibiotics
    • 4.1.6 Hormones
    • 4.1.7 Biopolymers
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Recombinant Proteins
    • 4.2.2 Monoclonal Antibodies
    • 4.2.3 Vaccines
    • 4.2.4 Cell Culture Media
    • 4.2.5 Biopharmaceuticals
    • 4.2.6 Diagnostic Reagents
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Contract Manufacturing
    • 4.3.2 Custom Synthesis
    • 4.3.3 Process Development
    • 4.3.4 Analytical Services
    • 4.3.5 Consultancy
    • 4.3.6 Regulatory Support
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Fermentation
    • 4.4.2 Biocatalysis
    • 4.4.3 Cell Culture
    • 4.4.4 Genetic Engineering
    • 4.4.5 Synthetic Biology
    • 4.4.6 Metabolic Engineering
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Raw Materials
    • 4.5.2 Intermediates
    • 4.5.3 Active Ingredients
    • 4.5.4 Excipients
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Pharmaceutical
    • 4.6.2 Food and Beverage
    • 4.6.3 Agriculture
    • 4.6.4 Cosmetics
    • 4.6.5 Animal Feed
    • 4.6.6 Biofuels
  • 4.7 Market Size & Forecast by Form (2020-2035)
    • 4.7.1 Liquid
    • 4.7.2 Powder
    • 4.7.3 Granule
    • 4.7.4 Pellet
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Upstream Processing
    • 4.8.2 Downstream Processing
    • 4.8.3 Formulation
    • 4.8.4 Purification
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Pharmaceutical Companies
    • 4.9.2 Biotechnology Firms
    • 4.9.3 Research Institutes
    • 4.9.4 Contract Research Organizations

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Form
      • 5.2.1.8 Process
      • 5.2.1.9 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Form
      • 5.2.2.8 Process
      • 5.2.2.9 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Form
      • 5.2.3.8 Process
      • 5.2.3.9 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Form
      • 5.3.1.8 Process
      • 5.3.1.9 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Form
      • 5.3.2.8 Process
      • 5.3.2.9 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Form
      • 5.3.3.8 Process
      • 5.3.3.9 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Form
      • 5.4.1.8 Process
      • 5.4.1.9 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Form
      • 5.4.2.8 Process
      • 5.4.2.9 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Form
      • 5.4.3.8 Process
      • 5.4.3.9 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Form
      • 5.4.4.8 Process
      • 5.4.4.9 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Form
      • 5.4.5.8 Process
      • 5.4.5.9 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Form
      • 5.4.6.8 Process
      • 5.4.6.9 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Form
      • 5.4.7.8 Process
      • 5.4.7.9 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Form
      • 5.5.1.8 Process
      • 5.5.1.9 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Form
      • 5.5.2.8 Process
      • 5.5.2.9 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Form
      • 5.5.3.8 Process
      • 5.5.3.9 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Form
      • 5.5.4.8 Process
      • 5.5.4.9 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Form
      • 5.5.5.8 Process
      • 5.5.5.9 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Form
      • 5.5.6.8 Process
      • 5.5.6.9 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Form
      • 5.6.1.8 Process
      • 5.6.1.9 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Form
      • 5.6.2.8 Process
      • 5.6.2.9 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Form
      • 5.6.3.8 Process
      • 5.6.3.9 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Form
      • 5.6.4.8 Process
      • 5.6.4.9 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Form
      • 5.6.5.8 Process
      • 5.6.5.9 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Lonza Group
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Catalent
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Evonik Industries
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Fujifilm Diosynth Biotechnologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Corbion
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Wacker Chemie
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Croda International
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Novozymes
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Merck KGa A
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Bio Vectra
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Cambrex Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Ajinomoto Bio Pharma Services
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Sartorius
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Genomatica
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Almac Group
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Boehringer Ingelheim Bio Xcellence
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ginkgo Bioworks
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Biocon
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Rentschler Biopharma
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 AGC Biologics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us